Warning signs: severe muscle pain, profound weakness, dark/cola urine
Statin-associated myotoxicity is a known risk; severe symptoms need urgent evaluation and stopping the drug pending clinician review (Harrison’s, p. 12814).
Liver injury (rare)
Warning signs: jaundice, dark urine, severe fatigue, right upper abdominal pain.
New-onset diabetes (small increased risk in susceptible patients, especially with higher-intensity statin use).
Kidney effects (rare; usually secondary to severe rhabdomyolysis).
Notes:
Rosuvastatin is generally well tolerated in studies, including South Asian populations, with no major differences in serious lab adverse events in comparative trials (Patient-Centered Management of Dyslipidemia: Part 2, p. 71).
Risk of muscle toxicity rises with interacting drugs (for statins broadly), higher doses, older age, renal impairment, and hypothyroidism.
If you want, I can give you a quick checklist of which symptoms are monitor-at-home vs seek urgent care while on rosuvastatin.
This is a shared conversation. Sign in to Orris to start your own chat.